Latest Articles

Publication Date
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com

Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com

Published: Oct. 8, 2025, 2:15 p.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Vulcan Post

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Vulcan Post

Published: Oct. 8, 2025, 7:33 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Malaysian Reserve

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Malaysian Reserve

Published: Oct. 8, 2025, 2:14 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Fidelity

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Fidelity

Published: Oct. 8, 2025, 1:35 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Manila Times

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Manila Times

Published: Oct. 8, 2025, 1:23 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - PR Newswire

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment PR Newswire

Published: Oct. 8, 2025, 1:08 a.m.
United States Endometriosis Treatment Market Report 2025: Pain - openPR.com

United States Endometriosis Treatment Market Report 2025: Pain openPR.com

Published: Sept. 29, 2025, 10:32 a.m.
Swedish Biotech Gesynta Advances Non-Hormonal Endometriosis Treatment - insights.citeline.com

Swedish Biotech Gesynta Advances Non-Hormonal Endometriosis Treatment insights.citeline.com

Published: Sept. 25, 2025, 7:42 a.m.
Dysregulation of Key Biological Processes in Endometriosis Pathophysiology.

Endometriosis is a typical disorder affecting the female reproductive system and is characterized by the presence of tissue resembling the endometrium both within and beyond the pelvic cavity. Unfortunately, the …

Published: Sept. 18, 2025, midnight
Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment.

Endometriosis is characterized by the presence of endometrial tissue outside the uterine cavity. The administration of drugs designated for this condition has significant adverse effects, such as signs of estrogen …

Published: Sept. 12, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!